- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01591239
Home-Based Program to Help Parents of Drug Abusing Adolescents
Parents as Interventionists for Moderate Drug Abusing Adolescents
Study Overview
Status
Intervention / Treatment
Detailed Description
Little attention has been paid to the large group of adolescents who use substances but are not, or not yet, dependent and who could successfully reduce substance use through early intervention. Brief interventions (BI) that are based in cognitive-behavioral and motivational interviewing (CB-MI) strategies provide an option for such mid-level drug abusers (e.g., DSM-IV substance abuse disorder), and extant research on them suggests this approach can be effective with youth.
Winters and colleagues have studied with controlled designs the efficacy of brief interventions for application to mild-to-moderate substance abusing adolescents. These studies have used the more traditional approach of counselor-led interventions. This program will be parent-led rather than directed by a counselor in a clinical setting.
The stage I activities will involve manual development, parent training development, and a small feasibility study; Stage II involves an efficacy trial. Two samples, 110 families each, will participate in the trial. Families will be assigned to either an intervention or control condition. Data to quantify intervention effects will be obtained by interviewing adolescents and the target parent at multiple time points (baseline and, 3-, 6- and 12-months post baseline). The investigators hypothesize that the home-based intervention will be superior to the control condition. In addition, the investigators expect response to the intervention by the adolescent to be mediated by motivation, cognitions, problem solving, peer drug use, parenting skills and parent self-efficacy. Secondary analyses will focus on additional predictors of intervention effects, and analyses of parent adherence, parent acceptance, and of training adherence.
The final product of the work will be a tested comparative intervention protocol that is shaped in an engaging and useful presentation format for use by parents.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55454
- University of Minnesota Medical School, Department of Psychiatry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Referral of the adolescent to the Minneapolis metro area participating sites.
- Both the parent and teen consent to participate.
Exclusion Criteria:
- Current developmental disorder or learning disorder.
- current or past history of psychosis, or any psychiatric or other condition that may interfere with ongoing participation in the intervention.
- Suicidal ideation or otherwise judged to be at risk to self or others
- Unstable or uncontrolled medical illnesses which may interfere with participation in the study.
- Inability to understand the study procedures or otherwise give informed assent for participation.
- Failure by the parent to give informed consent for the adolescent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Home-Based Intervention
Parents will receive a 1-session training on how to deliver a 3-session intervention across a 3-week period.
The intervention program begins with a 3 and a half hour training session delivered by the staff Trainer to the participating parent.
At the conclusion of training, the parent will be given the intervention manual and supplemental materials.
The trainer will phone the parent shortly before session 1, in between each intervention session, and after the third intervention (four phone calls total) to review the objectives and tasks associated with that week's intervention session and to help prepare for the coming session.
At the final phone call between the parent and trainer (after the third week), the trainer will deliver to the parent the follow-up resources.
|
Parents will be trained through a 3 1/2-hour series on providing a 3-session drug and alcohol intervention program to their adolescent.
The parent-led intervention will require parents to meet with their adolescent and work together to help strengthen family cohesiveness, enhance communication, and promote healthy life choices.
|
|
Active Comparator: Educational Group
Parents will receive a 2-hour, education-only psychoeducational curriculum (no parent-led intervention with their teen will occur.
|
Printed fact sheets will be delivered to parents in a single two-hour session.
These fact sheets will provide general drug-related information from the public domain (e.g., substance use trends and well-known dangers of substance involvement), and focus on communication approaches and talking points when discussing substance use with their adolescent (e.g., why adolescents use; how the media may influence attitudes about substances).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adolescent Substance Use
Time Frame: Changes from Baseline at 3-, 6-, and 12- months post-baseline
|
Adolescent participants will complete the Timeline Follow Back in order to assess days of drug use.
|
Changes from Baseline at 3-, 6-, and 12- months post-baseline
|
|
Adolescent Drug Use Consequences
Time Frame: Changes from Baseline at 3-, 6-, and 12- months post-baseline
|
The adolescent participant will complete the Personal Consequences Scale in order to measure their drug use consequences.
|
Changes from Baseline at 3-, 6-, and 12- months post-baseline
|
|
DSM-IV Substance Use Diagnosis
Time Frame: Changes from Baseline at 3-, 6-, and 12- months post-baseline
|
The Adolescent Diagnostic Interview (ADI) will be used to determine a diagnosis.
|
Changes from Baseline at 3-, 6-, and 12- months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adolescent Mental Health
Time Frame: Baseline and 3-, 6-, and 12- months post-baseline
|
Adolescent mental health will be measured in two ways.
The parent participant will complete the ADI-Parent version and the adolescent participant will complete the Comprehensive Adolescent Severity Inventory (CASI).
|
Baseline and 3-, 6-, and 12- months post-baseline
|
|
Adolescent Treatment History
Time Frame: Baseline and 3-, 6-, and 12- months post-baseline
|
Parent participants will provide this data when completing the ADI-Parent version.
|
Baseline and 3-, 6-, and 12- months post-baseline
|
|
Program Acceptability
Time Frame: Parent Training (average of 2 weeks post-baseline) and Post-Session 3 (average of 6 weeks after the parent training)
|
The Credibility/Expectancy Questionnaire (CEQ) will be completed by parents during the training session and the Working Alliance Inventory (WAI) will be completed my the parent after he or she completes the third training session with the adolescent.
|
Parent Training (average of 2 weeks post-baseline) and Post-Session 3 (average of 6 weeks after the parent training)
|
|
Program Satisfaction
Time Frame: Post-Session 3 (average of 6 weeks after the parent training)
|
Parents will complete a satisfaction questionnaire after completing the third session with the adolescent participant.
|
Post-Session 3 (average of 6 weeks after the parent training)
|
|
Training Fidelity
Time Frame: Parent Training (average of 2 weeks post-baseline)
|
A training fidelity checklist will be completed by an assessor following the training.
|
Parent Training (average of 2 weeks post-baseline)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ken Winters, Ph.D., Treatment Research Institute and University of Minnesota
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P50DA027841 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA); Rush University Medical CenterCompletedSubstance-Related Disorders | Substance Use | Substance AbuseUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentActive, not recruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
Clinical Trials on Home-Based Intervention
-
Thomas Jefferson UniversityCompleted
-
Thomas Jefferson UniversityCompleted
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedChronic Kidney Disease | End-stage Renal DiseaseUnited States
-
University of SalamancaNot yet recruitingLymphoma | Breast Cancer | Lung Cancer | Colon Cancer | Chronic Lymphocytic Leukemia (CLL) | Hematologic Cancer
-
California State University, Long BeachCompletedPhysical Inactivity
-
University of Alabama at BirminghamCompletedFemale Breast CancerUnited States
-
Northwestern UniversityPatient-Centered Outcomes Research InstituteCompletedPeripheral Artery DiseaseUnited States
-
Goethe UniversityAgaplesion Markus Krankenhaus gGmbHCompletedAdvanced Gastrointestinal CancerGermany
-
Thomas Jefferson UniversityCompleted
-
Paul ViscuseRecruitingMetastatic Prostate Cancer | Castrate Sensitive Prostate CancerUnited States